.

Name : Mr. ATI PAL SHARMA

Lab No. : 460141005 Age : 76 Years
Ref By : SELF Gender : Male
Collected : 19/12/2023 9:26:00AM Reported : 19/12/2023 2:13:04PM
A/c Status : P Report Status : Final
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

KIDNEY PANEL; KFT,SERUM

Creatinine 1.62 mg/dL 0.70 - 1.30

(Modified Jaffe,Kinetic)
GFR Estimated 43 mL/min/1.73m2 >59
(CKD EPI Equation 2021)
GFR Category G3b
(KDIGO Guideline 2012)
Urea 51.10 mg/dL 17.00 - 49.00
(Urease UV)
Urea Nitrogen Blood 23.86 mg/dL 8.00 - 23.00
(Calculated)
BUN/Creatinine Ratio 15
(Calculated)
Uric Acid 5.60 mg/dL 3.50 - 7.20
(Uricase)
Total Protein 8.00 g/dL 5.70 - 8.20
(Biuret)
Albumin 4.81 g/dL 3.20 - 4.60
(BCG)
A : G Ratio 1.51 0.90 - 2.00
(Calculated)
Globulin(Calculated) 3.19 gm/dL 2.0 - 3.5

Calcium, Total 9.80 mg/dL 8.80 - 10.20

(Arsenazo III)
Phosphorus 3.42 mg/dL 2.30 - 3.70
(Molybdate UV)
Sodium 138.00 mEq/L 136.00 - 145.00
(Indirect ISE)
Potassium 5.15 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 106.00 mEq/L 98.00 - 107.00
(Indirect ISE)
Advise
1. CKD Risk Map (Z1014)
2. Cystatin C, serum (B173)

Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.

*460141005* Page 1 of 5
.

Name : Mr. ATI PAL SHARMA

Lab No. : 460141005 Age : 76 Years
Ref By : SELF Gender : Male
Collected : 19/12/2023 9:26:00AM Reported : 19/12/2023 2:13:04PM
A/c Status : P Report Status : Final
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1

*460141005* Page 2 of 5
.

Name : Mr. ATI PAL SHARMA

Lab No. : 460141005 Age : 76 Years
Ref By : SELF Gender : Male
Collected : 19/12/2023 9:26:00AM Reported : 19/12/2023 2:13:04PM
A/c Status : P Report Status : Final
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

PROTHROMBIN TIME STUDIES

(Photo - Optical clot detection)
Mean Normal Prothrombin Time (PT) 11.00

Patient value 10.30 sec 9.70 - 12.40

Prothrombin Ratio (PR) 0.94

International Normalized Ratio (INR) 0.94 0.90 - 1.10

Note
1. INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy. Appropriate
therapeutic range varies with the disease and treatment intensity
2. Prolonged INR suggests potential bleeding disorder / bleeding complications
3. Results should be clinically correlated
4. Test conducted on Citrated plasma

Recommended Therapeutic range for Oral Anticoagulant therapy

INR 2.0-3.0 :
· Treatment of Venous thrombosis & Pulmonary embolism
· Prophylaxis of Venous thrombosis (High risk surgery)
· Prevention of systemic embolism in tissue heart valves, AMI, Valvular heart disease &
Atrial fibrillation
· Bileaflet mechanical valve in aortic position
INR 2.5-3.5:
§ Mechanical prosthetic valves
§ Systemic recurrent emboli

Comments
Prothrombin time measures the extrinsic coagulation pathway which consists of activated Factor VII (VIIa),
Tissue factor and Proteins of the common pathway (Factors X, V, II & Fibrinogen). This assay is used to
control long term oral anticoagulant therapy, evaluation of liver function & to evaluate coagulation disorders
specially factors involved in the extrinsic pathway like Factors V, VII, X, Prothrombin & Fibrinogen.

*460141005*
Page 3 of 5
.

Name : Mr. ATI PAL SHARMA

Lab No. : 460141005 Age : 76 Years
Ref By : SELF Gender : Male
Collected : 19/12/2023 9:26:00AM Reported : 19/12/2023 2:13:04PM
A/c Status : P Report Status : Final
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)

HbA1c 5.8 % 4.00 - 5.60

Estimated average glucose (eAG) 120 mg/dL

Interpretation
HbA1c result is suggestive of at risk for Diabetes (Prediabetes)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines

------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*460141005* Page 4 of 5
.

Name : Mr. ATI PAL SHARMA

Lab No. : 460141005 Age : 76 Years
Ref By : SELF Gender : Male
Collected : 19/12/2023 9:26:00AM Reported : 19/12/2023 2:13:04PM
A/c Status : P Report Status : Final
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal

MD, Pathology DM(Hematopathology), MD, Biochemistry MD,Pathology
Technical Director - Hematology & MD,DNB,MNAMS Sr. Consultant Biochemist Consultant Pathologist
Immunology Senior Consultant and Lead- NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd Hematopathology
NRL - Dr Lal PathLabs Ltd

Dr.Kamal Modi Dr Nimmi Kansal Dr Sarita Kumari Lal Dr Sunanda

MD, Biochemistry MD, Biochemistry MD, Pathology MD, Pathology
Consultant Biochemist Technical Director - Clinical Chemistry Consultant Pathologist Sr. Consultant Pathologist -
NRL - Dr Lal PathLabs Ltd & Biochemical Genetics Dr Lal PathLabs Ltd Hematology & Immunology
NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHIBLGNLCININNCBILLJCECCIICIKPKNKEDFJFAPPAHEEEHA
BNFFFNBPAPBDJPIGFGELEOIPAOAHFHALAKJOBCJGFLEKMOJHMPBNFFFNB
CIEGDAFNJNMIABJOPFIAAJHFJGFEHEDFNKPHENFLMLKIOEFLBLHDEHANP
DJAIAKFNBGBIEDIAAINELFMFAFPLAKBFJIFEPBPAKCLJPDNLIJHBKEMEK
IDMELHFJONNFDIAFEDGCKPJLKENLIDAHKKMHACEIPLKGKPNGKFFFOKMNC
KNCBBEFNMICGDIHKILELIIPBADHFOFAINCFCBKDLALIKONNALNEIOOMKL
LDIMIJFBELOKOPLIEKMEHGFHIHAFJBALPHGPBLMEOJCHKJFKIJNJIDILD
NJJJAMFNAKPMCELJGANHDCCILLBMFMBBOFCCAMNNIIKNOPNOBNFMAHILL
NKMGEKFMDOKGFAAAHNMIHMEKHMFFEKFBJFFKBLOFOOBIOCNKDJPHNEKLJ
POICOFFCELFJJDCFHLPFGPNEIDFKPNJHKEPBEDPLNKCKIGEOCFLKHOENK
JCIKOLFLGKCBMNCMPBBPFJEEINMGFEJBJMEEBFOEONDMKPFKEPCIGCIMO
IKICGJFCPLDNNCMMHHGHINAEIEOPPFOEBCNPBLNOOLJBIKNIOKONHDICL
MNNNNNEPKHCKMKGJOCFLHPCHJBAHFHAHLKPFCMNLMKJCLFNOAHFHAHIKL
APBBBPAPBNNAEJBMIPBKCFCFAGECHHCAONFFOKPGOLMHNLNNEDFCCBKHH
HHHHHHHPHHPPHPPHHPHPPPHPPPPPPPPPPPPHHPPPPHHHPHPHHHHHPHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

*460141005* Page 5 of 5